Case Report: A rare case of community-acquired Roseomonas mucosa sepsis that presented with persistently normal host-response biomarkers
Xiaomei Xu, Ying Li, Xin Huang

TL;DR
A 59-year-old woman with sepsis caused by Roseomonas mucosa was successfully treated with meropenem despite normal biomarker results.
Contribution
This case report highlights a rare instance of Roseomonas mucosa sepsis with normal host-response biomarkers.
Findings
Initial metagenomic analysis suggested Pseudomonas aeruginosa, but blood culture identified Roseomonas mucosa.
The patient was successfully treated with meropenem after antimicrobial susceptibility testing.
Host-response biomarkers remained negative despite septic shock progression.
Abstract
Community-acquired Roseomonas mucosa sepsis can lead to significant morbidity and mortality if not diagnosed promptly. We report a case of a 59-year-old woman with community-acquired Roseomonas mucosa sepsis who presented with persistent fever progressing to septic shock, despite repeatedly negative host-response biomarker results. Initial metagenomic analysis of peripheral blood suggested Pseudomonas aeruginosa infection. However, a peripheral blood culture identified Roseomonas mucosa as the causative pathogen. She was cured after switching to meropenem according to blood cultures and antimicrobial susceptibility testing.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsBacterial Identification and Susceptibility Testing · Infective Endocarditis Diagnosis and Management · Infections and bacterial resistance
